Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Excess comorbidity prevalence and cost associated with functional dyspepsia in an employed population.

Brook RA, Kleinman NL, Choung RS, Smeeding JE, Talley NJ.

Dig Dis Sci. 2012 Jan;57(1):109-18. doi: 10.1007/s10620-011-1822-8. Epub 2011 Jul 13.

PMID:
21750928
[PubMed - indexed for MEDLINE]
2.

Costs of physical and mental comorbidities among employees: a comparison of those with and without bipolar disorder.

Rajagopalan K, Kleinman NL, Brook RA, Gardner HH, Brizee TJ, Smeeding JE.

Curr Med Res Opin. 2006 Mar;22(3):443-52.

PMID:
16574028
[PubMed - indexed for MEDLINE]
3.

Functional dyspepsia impacts absenteeism and direct and indirect costs.

Brook RA, Kleinman NL, Choung RS, Melkonian AK, Smeeding JE, Talley NJ.

Clin Gastroenterol Hepatol. 2010 Jun;8(6):498-503. doi: 10.1016/j.cgh.2010.03.003. Epub 2010 Mar 19.

PMID:
20304102
[PubMed - indexed for MEDLINE]
4.

Posttraumatic stress disorder and physical comorbidity among female children and adolescents: results from service-use data.

Seng JS, Graham-Bermann SA, Clark MK, McCarthy AM, Ronis DL.

Pediatrics. 2005 Dec;116(6):e767-76.

PMID:
16322133
[PubMed - indexed for MEDLINE]
Free Article
5.

Actuarial analysis of private payer administrative claims data for women with endometriosis.

Mirkin D, Murphy-Barron C, Iwasaki K.

J Manag Care Pharm. 2007 Apr;13(3):262-72.

PMID:
17407392
[PubMed - indexed for MEDLINE]
Free Article
6.

Overlap of anxiety and depression in a managed care population: Prevalence and association with resource utilization.

McLaughlin TP, Khandker RK, Kruzikas DT, Tummala R.

J Clin Psychiatry. 2006 Aug;67(8):1187-93.

PMID:
16965195
[PubMed - indexed for MEDLINE]
7.

Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.

Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, Neumann PJ.

J Manag Care Pharm. 2010 May;16(4):264-75.

PMID:
20433217
[PubMed - indexed for MEDLINE]
Free Article
8.

Metabolic syndrome-related conditions among people with and without gout: prevalence and resource use.

Novak S, Melkonian AK, Patel PA, Kleinman NL, Joseph-Ridge N, Brook RA.

Curr Med Res Opin. 2007 Mar;23(3):623-30.

PMID:
17355743
[PubMed - indexed for MEDLINE]
9.

The epidemiology, diagnosis, and cost of dyspepsia and Helicobacter pylori gastritis: a case-control analysis in the Southwestern United States.

Mapel D, Roberts M, Overhiser A, Mason A.

Helicobacter. 2013 Feb;18(1):54-65. doi: 10.1111/j.1523-5378.2012.00988.x. Epub 2012 Sep 4.

PMID:
23067108
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States.

Shaib Y, El-Serag HB.

Am J Gastroenterol. 2004 Nov;99(11):2210-6.

PMID:
15555004
[PubMed - indexed for MEDLINE]
11.

Costs of acid-related disorders to a health maintenance organization.

Levin TR, Schmittdiel JA, Kunz K, Henning JM, Henke CJ, Colby CJ, Selby JV.

Am J Med. 1997 Dec;103(6):520-8.

PMID:
9428836
[PubMed - indexed for MEDLINE]
12.

Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.

Lin PJ, Shaya FT, Scharf SM.

Respir Med. 2010 May;104(5):697-704. doi: 10.1016/j.rmed.2009.11.009. Epub 2009 Dec 2.

PMID:
19954941
[PubMed - indexed for MEDLINE]
Free Article
13.

Healthcare utilization associated with dyspepsia in patients with arthritis.

Zhao SZ, Arguelles LM, Dedhiya SD, Morgan DG.

Am J Manag Care. 1999 Oct;5(10):1285-95.

PMID:
10622994
[PubMed - indexed for MEDLINE]
Free Article
14.

Health and economic burden of metabolic comorbidity among individuals with bipolar disorder.

Centorrino F, Mark TL, Talamo A, Oh K, Chang J.

J Clin Psychopharmacol. 2009 Dec;29(6):595-600. doi: 10.1097/JCP.0b013e3181bef8a6.

PMID:
19910727
[PubMed - indexed for MEDLINE]
15.

Economic implications of treatment-resistant depression among employees.

Greenberg P, Corey-Lisle PK, Birnbaum H, Marynchenko M, Claxton A.

Pharmacoeconomics. 2004;22(6):363-73.

PMID:
15099122
[PubMed - indexed for MEDLINE]
16.

Prevalence and health/social impacts of functional dyspepsia in Taiwan: a study based on the Rome criteria questionnaire survey assisted by endoscopic exclusion among a physical check-up population.

Lu CL, Lang HC, Chang FY, Chen CY, Luo JC, Wang SS, Lee SD.

Scand J Gastroenterol. 2005 Apr;40(4):402-11.

PMID:
16028434
[PubMed - indexed for MEDLINE]
17.

Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.

Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M.

J Manag Care Pharm. 2008 Mar;14(2):176-85.

PMID:
18331119
[PubMed - indexed for MEDLINE]
Free Article
18.

Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia.

Corsetti M, Caenepeel P, Fischler B, Janssens J, Tack J.

Am J Gastroenterol. 2004 Jun;99(6):1152-9.

PMID:
15180740
[PubMed - indexed for MEDLINE]
19.

Comorbidities, healthcare service utilization and costs for patients identified with painful DPN in a managed-care setting.

Ritzwoller DP, Ellis JL, Korner EJ, Hartsfield CL, Sadosky A.

Curr Med Res Opin. 2009 Jun;25(6):1319-28. doi: 10.1185/03007990902864749.

PMID:
19419344
[PubMed - indexed for MEDLINE]
20.

The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US.

Ivanova JI, Birnbaum HG, Samuels S, Davis M, Phillips AL, Meletiche D.

Pharmacoeconomics. 2009;27(8):681-91. doi: 10.2165/11314700-000000000-00000.

PMID:
19712010
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk